134 related articles for article (PubMed ID: 10748076)
1. Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein.
Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
J Biol Chem; 2000 May; 275(21):15948-54. PubMed ID: 10748076
[TBL] [Abstract][Full Text] [Related]
2. Endoproteolytic cleavage of human thyroperoxidase: role of the propeptide in the protein folding process.
Le Fourn V; Ferrand M; Franc JL
J Biol Chem; 2005 Feb; 280(6):4568-77. PubMed ID: 15590661
[TBL] [Abstract][Full Text] [Related]
3. Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking.
Fayadat L; Niccoli-Sire P; Lanet J; Franc JL
Endocrinology; 1998 Oct; 139(10):4277-85. PubMed ID: 9751510
[TBL] [Abstract][Full Text] [Related]
4. Competition between calnexin and BiP in the endoplasmic reticulum can lead to the folding or degradation of human thyroperoxidase.
Le Fourn V; Siffroi-Fernandez S; Ferrand M; Franc JL
Biochemistry; 2006 Jun; 45(23):7380-8. PubMed ID: 16752927
[TBL] [Abstract][Full Text] [Related]
5. Calnexin and calreticulin binding to human thyroperoxidase is required for its first folding step(s) but is not sufficient to promote efficient cell surface expression.
Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
Endocrinology; 2000 Mar; 141(3):959-66. PubMed ID: 10698171
[TBL] [Abstract][Full Text] [Related]
6. Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis.
McGee TP; Cheng HH; Kumagai H; Omura S; Simoni RD
J Biol Chem; 1996 Oct; 271(41):25630-8. PubMed ID: 8810339
[TBL] [Abstract][Full Text] [Related]
7. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
[TBL] [Abstract][Full Text] [Related]
8. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator.
Gelman MS; Kannegaard ES; Kopito RR
J Biol Chem; 2002 Apr; 277(14):11709-14. PubMed ID: 11812794
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance.
Bush KT; Goldberg AL; Nigam SK
J Biol Chem; 1997 Apr; 272(14):9086-92. PubMed ID: 9083035
[TBL] [Abstract][Full Text] [Related]
10. The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.
Bebök Z; Mazzochi C; King SA; Hong JS; Sorscher EJ
J Biol Chem; 1998 Nov; 273(45):29873-8. PubMed ID: 9792704
[TBL] [Abstract][Full Text] [Related]
11. Cell type-dependent differences in thyroid peroxidase cell surface expression.
Zhang X; Arvan P
J Biol Chem; 2000 Oct; 275(41):31946-53. PubMed ID: 10924504
[TBL] [Abstract][Full Text] [Related]
12. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity.
Qu D; Teckman JH; Omura S; Perlmutter DH
J Biol Chem; 1996 Sep; 271(37):22791-5. PubMed ID: 8798455
[TBL] [Abstract][Full Text] [Related]
13. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP.
Skovronsky DM; Pijak DS; Doms RW; Lee VM
Biochemistry; 2000 Feb; 39(4):810-7. PubMed ID: 10651647
[TBL] [Abstract][Full Text] [Related]
14. Proteasome and thiol involvement in quality control of glycosylphosphatidylinositol anchor addition.
Wilbourn B; Nesbeth DN; Wainwright LJ; Field MC
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):111-8. PubMed ID: 9576858
[TBL] [Abstract][Full Text] [Related]
15. Degradation of HMG-CoA reductase in vitro. Cleavage in the membrane domain by a membrane-bound cysteine protease.
Moriyama T; Sather SK; McGee TP; Simoni RD
J Biol Chem; 1998 Aug; 273(34):22037-43. PubMed ID: 9705346
[TBL] [Abstract][Full Text] [Related]
16. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate.
Werner ED; Brodsky JL; McCracken AA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13797-801. PubMed ID: 8943015
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
de Virgilio M; Weninger H; Ivessa NE
J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
[TBL] [Abstract][Full Text] [Related]
18. A plasminogen-like protease in thyroid rough microsomes degrades thyroperoxidase and thyroglobulin.
Giraud A; Lejeune PJ; Barbaria J; Mallet B
Endocrinology; 2007 Jun; 148(6):2886-93. PubMed ID: 17332062
[TBL] [Abstract][Full Text] [Related]
19. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
20. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
